ArticleMolecular cancer2019

Correction to: N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ ATM pathway.

Yu Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.